Breast cancer :: Immune therapy for metastatic breast cancer
Researchers at the National Cancer Institute (NCI), one of
the National Institutes of Health, have found promising
evidence that immune cell transplant therapy can help
shrink tumors in patients with metastatic breast cancer.
Similar therapies, which also involve transplantation of
donated immune cells, have produced dramatic anti-tumor
effects in leukemias and lymphomas-cancers of the blood
and lymph, respectively. However, previous studies have
not proven that such therapies have clinical effects on
breast cancer.